PA
BMY icon

Promethium Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Promethium Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.71M Buy
44,650
+600
+1% +$35K 1.4% 23
2025
Q4 		$2.38M Hold
44,050
– – 1.28% 24
2025
Q3 		$1.99M Hold
44,050
– – 1.14% 33
2025
Q2 		$2.04M Sell
44,050
-2,000
-4% -$98.2K 1.24% 30
2025
Q1 		$2.81M Sell
46,050
-10,000
-18% -$583K 1.8% 17
2024
Q4 		$3.17M Sell
56,050
-13,500
-19% -$754K 2.17% 8
2024
Q3 		$3.6M Buy
+69,550
New +$3.26M 2.54% 4

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Promethium Advisors's BMY Position: Q1 2026 in Review

Promethium Advisors increased its Bristol-Myers Squibb (BMY) stake by 1.4% in Q1 2026, buying an estimated $35K and bringing the position to 44,650 shares worth $2.71M. The position accounts for 1.4% of the portfolio, ranked #23.

Promethium Advisors first reported a position in BMY in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.6M in Q3 2024. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Promethium Advisors held 44,650 shares of Bristol-Myers Squibb worth $2.71M as of Q1 2026.
  • Promethium Advisors bought 600 Bristol-Myers Squibb shares in Q1 2026, an estimated $35K.
  • Bristol-Myers Squibb made up 1.4% of Promethium Advisors's portfolio in Q1 2026, its #23 holding.
  • Promethium Advisors first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 7 quarters since.
  • Promethium Advisors's Bristol-Myers Squibb position peaked at $3.6M in Q3 2024.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Promethium Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.